Advertisement
Screener

Nektar Therapeutics (NKTR) ROE

Nektar Therapeutics (NKTR) ROE

  • 2026-06-30: ROE -17.40%.
  • 2026-03-31: ROE -27.44%.
  • 2025-12-31: ROE -182.65%.
  • 2025-09-30: ROE -141.90%.

Complete source-backed roe history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-17.40%
2026-03-31-27.44%
2025-12-31-182.65%
2025-09-30-141.90%
2025-06-30505.02%
2025-03-31-968.42%
2024-12-31-195.86%
2024-09-30-344.29%
2024-06-30-222.22%
2024-03-31-138.78%
2023-12-31-210.75%
2023-09-30-184.27%
2023-06-30-155.81%
2023-03-31-172.22%
2022-12-31-100.43%
2022-09-30-110.17%
2022-06-30-114.40%
2022-03-31-80.81%
2021-12-31-77.09%
2021-09-30-61.81%
2021-06-30-52.41%
2021-03-31-43.11%
2020-12-31-41.26%
2020-09-30-37.52%
2020-06-30-34.18%
2020-03-31-35.46%
2019-12-31-31.36%
2019-09-30-28.66%
2019-06-30-27.25%
2019-03-3140.25%
2018-12-3139.67%
2018-09-3041.66%
2018-06-3048.52%
2018-03-31-220.68%
2017-12-31-110.09%
2017-09-30-124.84%
2017-06-30-6177.20%
2017-03-31-442.23%
2016-12-31-174.21%
2016-09-30243.85%
2016-06-30332.33%
2016-03-3148907.27%
2015-12-31-1262.67%
2015-09-30-186.22%
2015-06-3017.34%
2015-03-3133.77%
2014-12-31-148.40%
2014-09-30-118.37%
2014-06-30404.52%
2014-03-311561.33%
2013-12-31180.21%
2013-09-30332.90%
2013-06-30479.13%
2013-03-317092.40%
2012-12-31-365.51%
2012-09-30-164.08%
2012-06-30-103.52%
2012-03-31-85.57%
2011-12-31-67.73%
2011-09-30-51.59%
2011-06-30-41.27%
2011-03-31-24.12%
2010-12-31-41.85%

Annual ROE

DateROE
2025-12-31-182.65%
2024-12-31-195.86%
2023-12-31-210.75%
2022-12-31-100.43%
2021-12-31-77.09%
2020-12-31-41.26%
2019-12-31-31.36%
2018-12-3139.67%
2017-12-31-110.09%
2016-12-31-174.21%
2015-12-31-1262.67%
2014-12-31-148.40%
2013-12-31180.21%
2012-12-31-365.51%
2011-12-31-67.73%
2010-12-31-41.85%
2009-12-31-100.15%

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Generate Biomedicines, Inc. (GENB)United States$2.052B
Biohaven Ltd. (BHVN)United States$1.990B-3.83
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89